Provention Bio, Inc.
USD24.98
+0.00 (+0.00%)
CEO
Ashleigh W. Palmer
IPO Date
2018-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$24.98
Prev. Close
$24.98
Day Low
$24.98
Day High
$25.00
52W Low
$3.19
52W High
$25.00
Market Cap
$2.38B
Volume
9.12M
| -3.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 55.5% | -76.7% | -0.00 | 7.56 | -9.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 53.4% | 56.1% | 0.00 | 22.39 | -14.4 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -44.4% | -43.0% | 0.00 | 32.89 | -1.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -45.3% | -40.7% | 0.00 | 17.54 | -17.8 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.43 | 0.0 |
| -3.3 |
| 30 Jun 2022 | Q2 | 100.0% | -3959.9% | -37.5% | -28.3% | 0.01 | 3.59 | -2.2 |
| 31 Mar 2022 | Q1 | 100.0% | -3787.6% | -23.3% | -17.9% | 0.01 | 3.39 | -5.3 |
| 31 Dec 2021 | Q4 | 100.0% | -3602.2% | -23.3% | -19.0% | 0.01 | 4.44 | -3.4 |
| 30 Sept 2021 | Q3 | 100.0% | -3985.5% | -20.1% | -17.1% | 0.00 | 7.46 | -3.8 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -18.4% | -15.9% | 0.00 | 7.33 | -4.6 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -17.6% | -15.2% | 0.00 | 7.91 | -5.0 |
| 31 Dec 2020 | Q4 | 0.0% | 0.0% | 18.3% | -25.3% | -0.00 | 7.56 | -7.3 |
| 30 Sept 2020 | Q3 | 0.0% | 0.0% | -23.1% | -20.6% | 0.00 | 9.23 | -5.8 |